13.07.2015 Views

Managing Complications in Pregnancy and Childbirth: - IAWG

Managing Complications in Pregnancy and Childbirth: - IAWG

Managing Complications in Pregnancy and Childbirth: - IAWG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

C-26 Cl<strong>in</strong>ical use of blood, blood products <strong>and</strong> replacement fluidsThe fundamental pr<strong>in</strong>ciple of the appropriate use of blood or bloodproduct is that transfusion is only one element of the woman’smanagement. When there is sudden rapid loss of blood due tohaemorrhage, surgery or complications of childbirth, the most urgentneed is usually the rapid replacement of the fluid lost from circulation.Transfusion of red cells may also be vital to restore the oxygen-carry<strong>in</strong>gcapacity of the blood.M<strong>in</strong>imize “wastage” of a woman’s blood (to reduce the need fortransfusion) by:• us<strong>in</strong>g replacement fluids for resuscitation;• m<strong>in</strong>imiz<strong>in</strong>g the blood taken for laboratory use;• us<strong>in</strong>g the best anaesthetic <strong>and</strong> surgical techniques to m<strong>in</strong>imizeblood loss dur<strong>in</strong>g surgery;• salvag<strong>in</strong>g <strong>and</strong> re<strong>in</strong>fus<strong>in</strong>g surgical blood lost dur<strong>in</strong>g procedures(autotransfusion), where appropriate (page S-14).Pr<strong>in</strong>ciples to remember:• Transfusion is only one element of manag<strong>in</strong>g a woman.• Decisions about prescrib<strong>in</strong>g a transfusion should be based onnational guidel<strong>in</strong>es on the cl<strong>in</strong>ical use of blood, tak<strong>in</strong>g the woman’sneeds <strong>in</strong>to account.• Blood loss should be m<strong>in</strong>imized to reduce the woman’s need fortransfusion.• The woman with acute blood loss should receive effectiveresuscitation (IV replacement fluids, oxygen, etc.) while the needfor transfusion is be<strong>in</strong>g assessed.• The woman’s haemoglob<strong>in</strong> value, although important, should notbe the sole decid<strong>in</strong>g factor <strong>in</strong> start<strong>in</strong>g the transfusion. The decisionto transfuse should be supported by the need to relieve cl<strong>in</strong>icalsigns <strong>and</strong> symptoms <strong>and</strong> prevent significant morbidity <strong>and</strong>mortality.• The cl<strong>in</strong>ician should be aware of the risks of transfusiontransmissible<strong>in</strong>fection <strong>in</strong> blood products that are available.• Transfusion should be prescribed only when the benefits to thewoman are likely to outweigh the risks.• A tra<strong>in</strong>ed person should monitor the transfused woman <strong>and</strong>respond immediately if any adverse effects occur (page C-27).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!